ConductScience.org, home

Paper39744696

B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications.

Wu X and 5 others. Theranostics, 2025. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications. Papers, record 39744696. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39744696

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications.
PubMed
Journal
Theranostics
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
7.56, provisional
iCite
Revised in PubMed
2025-06-04
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu XXing
2Huang QQibo
3Chen XXiaoping
4Zhang BBinhao
5Liang JJunnan
6Zhang BBixiang

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tertiary Lymphoid StructuresMajor topic
B-LymphocytesMajor topic
Tumor MicroenvironmentMajor topic
NeoplasmsMajor topic
Lymphocytes, Tumor-InfiltratingMajor topic
Humans
Animals

Source PubMed

Download CSV of topics

References207

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137470151Immune-related adverse events with bispecific T-cell engager therapy targeting B-cell maturation antigen.Haematologica2024https://conductscience.org/library/papers/37470151PubMed
234417437Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence.Signal Transduct Target Ther2021https://conductscience.org/library/papers/34417437PubMed
326715642Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia.Cancer Discov2016https://conductscience.org/library/papers/26715642PubMed
414523388Plasma-cell homing.Nat Rev Immunol2003https://conductscience.org/library/papers/14523388PubMed
533314398Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome.Brain Pathol2021https://conductscience.org/library/papers/33314398PubMed
637278484Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2-negative breast cancer.Cancer Commun (Lond)2023https://conductscience.org/library/papers/37278484PubMed
737602821The Tumor Immune Microenvironment Architecture Correlates with Risk of Recurrence in Head and Neck Squamous Cell Carcinoma.Cancer Res2023https://conductscience.org/library/papers/37602821PubMed
837046094Antibodies against endogenous retroviruses promote lung cancer immunotherapy.Nature2023https://conductscience.org/library/papers/37046094PubMed
937814076Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma.Cell Oncol (Dordr)2024https://conductscience.org/library/papers/37814076PubMed
1032146518Adenosine-producing regulatory B cells in head and neck cancer.Cancer Immunol Immunother2020https://conductscience.org/library/papers/32146518PubMed
1124475900Tumor infiltrating B-cells are increased in prostate cancer tissue.J Transl Med2014https://conductscience.org/library/papers/24475900PubMed
1231988391B cells, plasma cells and antibody repertoires in the tumour microenvironment.Nat Rev Immunol2020https://conductscience.org/library/papers/31988391PubMed
1325529861Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer.Oncol Rep2015https://conductscience.org/library/papers/25529861PubMed
1428768193Immunogenetic Profiling for Gastric Cancers Identifies Sulfated Glycosaminoglycans as Major and Functional B Cell Antigens in Human Malignancies.Cell Rep2017https://conductscience.org/library/papers/28768193PubMed
1533627414Plasma cells shape the mesenchymal identity of ovarian cancers through transfer of exosome-derived microRNAs.Sci Adv2021https://conductscience.org/library/papers/33627414PubMed
1611869683Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation.Immunity2002https://conductscience.org/library/papers/11869683PubMed
1738039777Atypical B cells (CD21-CD27-IgD-) correlate with lack of response to checkpoint inhibitor therapy in NSCLC.Eur J Cancer2024https://conductscience.org/library/papers/38039777PubMed
1837057967Nanovaccines Fostering Tertiary Lymphoid Structure to Attack Mimicry Nasopharyngeal Carcinoma.ACS Nano2023https://conductscience.org/library/papers/37057967PubMed
1938514660Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.Nat Commun2024https://conductscience.org/library/papers/38514660PubMed
2026787825Comprehensive Immune Profiling of Lung Adenocarcinomas Reveals Four Immunosubtypes with Plasma Cell Subtype a Negative Indicator.Cancer Immunol Res2016https://conductscience.org/library/papers/26787825PubMed

See all 207 referencesDownload CSV of references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
42903730Spatial and maturational characterisation of tertiary lymphoid structures predicts immunotherapy response in extensive-stage small cell lung cancer.Clin Transl Immunology2026https://conductscience.org/library/papers/42903730PubMed
42828165Metabolite-driven dysfunction of intratumoral tertiary lymphoid structures: single-cell and spatial omics perspectives on cancer immune escape.Front Immunol2026https://conductscience.org/library/papers/42828165PubMed
42706236B cells in cancer: functions, mechanisms and therapeutic advances.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42706236PubMed
42693308Tertiary lymphoid structures in cancer: their development, composition, clinical prognosis, and the drivers of the anti-tumor responses.Mol Biomed2026https://conductscience.org/library/papers/42693308PubMed
42630932Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions.Front Oncol2026https://conductscience.org/library/papers/42630932PubMed
42613326Humoral immunity in cancer.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42613326PubMed
42588612Beyond TLS Presence: A Functional Framework Integrating Maturity, Location, and Immune Context.Cancers (Basel)2026https://conductscience.org/library/papers/42588612PubMed
42578817Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer.Cancer Res2026https://conductscience.org/library/papers/42578817PubMed
42453886Efficacy and challenges of immunotherapy in advanced EGFR-mutant NSCLC: a case report.Front Oncol2026https://conductscience.org/library/papers/42453886PubMed
42449297The Ki-67 proliferation index in tertiary lymphoid structures as a predictor of survival outcomes in patients with resectable non-small cell lung cancer.BMC Cancer2026https://conductscience.org/library/papers/42449297PubMed
42362948Regulatory B-cell states in NSCLC immunotherapy resistance: mechanisms, spatial context and translational implications.Cancer Immunol Immunother2026https://conductscience.org/library/papers/42362948PubMed
42310755Cancer-associated fibroblasts and tertiary lymphoid structure orchestrate the spatial architecture of tumor immunity.J Hematol Oncol2026https://conductscience.org/library/papers/42310755PubMed
42292480Tumor immune microenvironment states inferred from TLS-associated immune-cell composition stratify prognosis in hepatocellular carcinoma.Front Immunol2026https://conductscience.org/library/papers/42292480PubMed
42291273Tumor infiltrating B cells and tertiary lymphoid structures in pancreatic cancer prognosis and therapy.iScience2026https://conductscience.org/library/papers/42291273PubMed
42053688Dynamic changes in peripheral B and NK cells reflect treatment response in breast cancer subtypes.Discov Oncol2026https://conductscience.org/library/papers/42053688PubMed
42004077Integrated bulk and single-cell transcriptomics with experimental validation to identify calmodulin-related prognostic genes in lung adenocarcinoma.Am J Cancer Res2026https://conductscience.org/library/papers/42004077PubMed
41992249Single-cell and spatial transcriptomic analysis reveals PAX5's role and regulatory mechanisms in gastric adenocarcinoma lymph node metastasis.J Transl Med2026https://conductscience.org/library/papers/41992249PubMed
41895712Spatial and phenotypic plasticity of B cells in remodeling the tumor microenvironment.J Immunother Cancer2026https://conductscience.org/library/papers/41895712PubMed
41726230Ferroptosis and immunity: rewiring the tumor microenvironment for therapy.RSC Adv2026https://conductscience.org/library/papers/41726230PubMed
41700140Pan-cancer multi-omics profiling of OAS3 reveals its immunological and prognostic associations across human cancers.PeerJ2026https://conductscience.org/library/papers/41700140PubMed

See all 30 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39744696

GET https://conductscience.org/api/papers/v1/39744696/references?page=2